Mindfulness relapse prevention that tracks heart rate and mood for people with alcohol problems.
Official title: Mindfulness-Based Relapse Prevention and Psychophysiological Self-Regulation
Run by University of New Mexico · NCT06982443 · Data updated 2026-11-12
This program tests whether an 8-week mindfulness-based relapse prevention course plus wearable heart-rate sensors and three daily surveys can reduce drinking and improve self-regulation in adults with moderate to severe alcohol use disorder.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 120 (estimated) |
| Sponsor | University of New Mexico Academic / other |
| Locations | 1 site (Albuquerque, New Mexico) |
| Status | Recruiting |
| Started | October 1, 2025 |
| Main results expected | March 31, 2028 |
| Study ends | September 1, 2029 |
| Registry record updated | July 15, 2026 |
| Trial ID | NCT06982443 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults 18 or older in the United States who meet criteria for moderate to severe alcohol use disorder, can read English, have internet access and a U.S. mailing address, can attend weekly group sessions, and are willing to wear and return the HRV sensor are ideal candidates.
✕Probably not a fit
People with current psychosis or mania, those requiring inpatient detoxification or higher-level substance use care, or individuals with cardiac conditions that interfere with HRV data collection may not benefit or be eligible.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This single-group study enrolls 120 adults with moderate to severe alcohol use disorder to receive eight weekly mindfulness-based relapse prevention (MBRP) groups. Participants are mailed wearable heart-rate variability (HRV) sensors to wear before, during, and after each weekly group and complete three brief surveys per day during the treatment period. Investigators will measure resting, reactivity, and recovery HRV week-to-week and link changes in HRV to daily drinking, craving, and negative affect. Participants also complete baseline and 3- and 6-month follow-ups to track drinking outcomes after treatment.
Why it matters
Potential benefit: If successful, this approach could help identify physiological signs of poor self-regulation and reduce drinking by timing or tailoring relapse-prevention strategies.
How similar studies have gone: Mindfulness-based relapse prevention has shown promise in reducing relapse and cravings in prior trials, while using wearable HRV monitoring in this context is an emerging approach with limited prior large-scale evidence.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. 18 years of age or older 2. Meet criteria for a moderate to severe alcohol use disorder within the previous 3-months. 3. Able to attend group meetings at the time listed on the recruitment materials. 4. Willing to wear a sensor for the 8-week intervention period and return the sensor after the immediate follow-up. 5. Have a phone/tablet/computer with internet access. 6. Be able to comprehend and consent to study requirements in English. 7. Have access to a valid U.S. mailing address for receiving the HRV sensors and reside in the United States. Exclusion Criteria: 1. Current symptoms of psychosis or mania. 2. Have a substance use disorder requiring a higher level of care than outpatient treatment (e.g., severe alcohol use disorder requiring inpatient detoxification). 3. Have a history of pulmonary or cardiovascular disease that interferes with sensor data collection and HRV metrics (i.e., ectopic beats, arrythmia, congenital heart disease).
Where it's running
-
University of New Mexico
Albuquerque, New Mexico, United States Recruiting
Study contacts
- Principal investigator: Matison W McCool, Phd — Center on Alcohol, Substance use, And Addictions - The University of New Mexico
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Smartphone-based Intervention for Young Adults with ADHD and Risky Drinking
A smartphone-based program is tested to see if it's doable and helpful for young adults with ADHD who also drink at risky levels.
-
Postpartum mood and alcohol use: a CM-PST approach for new mothers
This study tests whether a six-week CM-PST program helps reduce depressive symptoms and alcohol use in new mothers within the first year after birth.
-
Mindfulness Relapse Prevention for Smoking and Alcohol in Cancer Survivors
This study tests whether Mindfulness-Based Relapse Prevention for Smoking and Alcohol (MBRP-SA) helps cancer survivors quit smoking and reduce risky drinking compared with standard care.
-
Proactive Automatized Lifestyle Intervention for Multiple Health Risk Behaviors
This trial tests a proactive, automated program to help hospital patients reduce tobacco and alcohol use, eat better, and exercise more.
-
Brief alcohol-focused program tailored for people taking buprenorphine
This project will try a short, opioid-informed alcohol counseling program for adults on prescribed buprenorphine who drink alcohol to see if it reduces drinking and helps them stay in treatment.
-
College student strategies to reduce alcohol-related harm
This trial will test whether adding personalized goal-setting helps college students who drink weekly use protective behavioral strategies more and cut down on risky drinking and harms.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.